文献速递消化内镜消化道肿瘤与早癌

预防性抗生素预防结直肠内镜黏膜下剥离术后电凝综合征的随机对照试验

A randomized controlled trial of prophylactic antibiotics in the prevention of electrocoagulation syndrome after colorectal endoscopic submucosal dissection.
PubMed 文献 · Gastrointest Endosc · 2016-11-27

该随机对照试验将接受结直肠内镜黏膜下剥离术(ESD)的患者随机分为两组,比较预防性使用氨苄西林和/或舒巴坦与安慰剂对术后电凝综合征(PEECS)的影响。结果显示,抗生素组PEECS发生率、C反应蛋白≥1 mg/dL患者数及腹痛VAS评分≥1患者数均低于对照组,作者认为预防性抗生素可能有效降低PEECS风险。

要点

  • 结直肠ESD后预防性使用氨苄西林和/或舒巴坦可降低PEECS发生率(1例 vs 8例,P = .031)。
  • 抗生素组C反应蛋白≥1 mg/dL患者数少于对照组(P = .008)。
  • 抗生素组腹痛VAS评分≥1患者数少于对照组(P = .023)。

核心结论

  • 结直肠ESD预防性使用氨苄西林和/或舒巴坦与降低PEECS风险、降低C反应蛋白水平及减轻腹痛相关。
  • 作者认为结直肠ESD预防性使用抗生素可能是降低PEECS风险的有效工具。

研究设计与样本

  • 随机对照试验,将接受结直肠ESD的患者随机分配至2种治疗方案之一,最终分析100例(每组50例),97个肿瘤成功整块切除。
  • 第1组在ESD前1小时给予氨苄西林和/或舒巴坦与生理盐水混合液,之后每8小时再给药两次;第2组按相同时间表给予不含抗生素的生理盐水。

主要发现

  • 第2组C反应蛋白≥1 mg/dL的患者数多于第1组(P = .008)。
  • 第2组腹痛VAS评分≥1的患者数多于第1组(P = .023)。
  • 第2组PEECS发生率高于第1组(第1组1例 vs 第2组8例,P = .031)。

临床怎么用

  • 作者认为结直肠ESD预防性使用抗生素可能是降低PEECS风险的有效工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Endoscopic submucosal dissection (ESD) is currently commonly performed, but colorectal ESD has a substantial risk of adverse events, including post-ESD electrocoagulation syndrome (PEECS). We investigated whether the use of prophylactic antibiotics can reduce the occurrence of PEECS. METHODS: Patients who underwent colorectal ESD were randomly assigned to 1 of 2 treatment regimens. Ampicillin and/or sulbactam mixed with normal saline solution was administered 1 hour before ESD in group 1 then additionally injected every 8 hours twice more. In group 2, normal saline solution without antibiotics was administered following the same schedule. We investigated the characteristics of the patients and tumors, the incidence of PEECS, laboratory findings, and the visual analog scale (VAS) score for abdominal pain measured on the morning after ESD. RESULTS: A total of 100 cases (50 per group) were finally analyzed, and 97 tumors were successfully resected en bloc. The number of patients having C-reactive protein (CRP) levels ≥1 mg/dL and the number of patients having VAS scores for abdominal pain ≥1 were greater in group 2 than in group 1 (P = .008 and .023, respectively). The incidence of PEECS in group 2 also was higher than that in group 1 (1 and 8 in groups 1 and 2, respectively; P = .031). CONCLUSIONS: The prophylactic use of ampicillin and/or sulbactam in colorectal ESD is associated with reduced risk of PEECS, decreased CRP levels, and decreased abdominal pain. The use of prophylactic antibiotics in colorectal ESD may be an effective tool for reducing the risk of PEECS. (Clinical trial registration number: KCT0001102.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Lee SP, Sung IK, Kim JH, et al. A randomized controlled trial of prophylactic antibiotics in the prevention of electrocoagulation syndrome after colorectal endoscopic submucosal dissection. Gastrointest Endosc. 2016. PMID: 27899322. doi:10.1016/j.gie.2016.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。